CNBC·48 event signal
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
businessLLY
One of Eli Lilly's buildings in San Diego, California, Nov. 21, 2025.Mike Blake | ReutersEli Lilly on Monday said its obesity pill Foundayo significantly reduced the severity of obstructive sleep apnea, the...
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Source: FreeNewsAPIRead at CNBC
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.